Drug Information
Resources
Browse PDR's full list of drug information
FDA Date: 5/11/15
Goal of the AndroGel (testosterone gel) 1% REMS Program
To inform patients about the serious risks associated with the use of AndroGel (testosterone gel) 1%.
• Medication Guide
Open the Full REMS Notification
REMS Summary of Terms